Connection

Besim Ogretmen to Dexamethasone

Back to Details
This is a "connection" page, showing publications Besim Ogretmen has written about Dexamethasone.
Besim Ogretmen
Connection Strength
0.050
Dexamethasone
  1. Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma. Ann Hematol. 2023 Feb; 102(2):369-383.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.